Venture capital firms in Jiangsu, China
Updated 9 Nov 2026
Not sure about the data?
Download a free 25-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Addor Capital | Venture capital firm | Nanjing | •••@addorcapital.com | 025-85••• |
| Oriza Holdings | Venture capital firm | Suzhou | •••@oriza.com.cn | |
| BioVenture | Venture capital firm | Suzhou | •••@bioventure.com.cn | +86512••• |
| SND Ventures Group | Private equity firm | Suzhou | •••@sndvc.com | 86-512••• |
| Huatai Zijin Investment | Venture capital firm | Nanjing | •••@gmail.com | 025-83••• |
| Wuxi Capital | Angel group | Wuxi Shi | •••@wxfig.com | 0510-8••• |
| Nanjing Innovation Capital Group | Venture capital firm | Nanjing | •••@njicg.com | 025-86••• |
| Zijin High-Tech Venture Capital | Venture capital firm | Nanjing | •••@163.com |
8 rows of the CSV in 5 of its 14 columns, email and phone masked.
- 29 of the 109 venture capital firms in Jiangsu, China have a published email address, 45 a phone number and 64 a website.
- Addor Capital has the most recorded investments, 350, 173 of them as lead investor.
- 23 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Addor Capital is an investor in 7 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Micronano Core's $150.0M Series C on 28 October 2026.
- Software is the most common sector across their 332 portfolio companies (47%).
- Early stage venture is the most common investment stage, recorded for 90 of them (83%).
Source: FundingWatcher. Data as of 9 November 2026. "Last 12 months" is the 365 days to that date.
Venture capital firms in Jiangsu, China
30 of 109, most investments first| # | Investor | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Addor Capital | Nanjing | Hardware, Artificial intelligence | Micronano Core, Layerwave Bio, Kunwei Technology | 7 | 350 | 173 | 26 | •••@addorcapital.com | 025-85••• | In the CSV |
| 2 | Oriza Holdings | Suzhou | Hardware, Artificial intelligence | Mogulinker Technology, Muchuang, Listenai | 7 | 220 | 56 | 22 | •••@oriza.com.cn | In the CSV | |
| 3 | BioVenture | Suzhou | Health care, Biotech | AusperBio, Degron Therapeutics, AccuPulse | 5 | 182 | 60 | 13 | •••@bioventure.com.cn | +86512••• | |
| 4 | Highlight Capital | Nanjin | Artificial intelligence, Health care | EdgeRock, Artivila Therapeutics, ENGINEAI | 5 | 166 | 59 | 15 | +86216••• | In the CSV | |
| 5 | Oriza Seed Capital (Oriza Yuandian) | Suzhou | Health care, Hardware | Mogulinker Technology, Simnova, Aerofugia | 4 | 147 | 43 | 10 | |||
| 6 | Jolmo Capital | Nanjing | Hardware, Health care | SAGE Intelligent | 1 | 100 | 38 | 7 | 025-84••• | In the CSV | |
| 7 | Suzhou International Development Venture Capital | Suzhou | Hardware, Artificial intelligence | Kossel Medical, Zhilun Ultra-Pure, Gazer | 4 | 93 | 20 | 6 | +86 51••• | In the CSV | |
| 8 | SND Ventures Group | Suzhou | Hardware, Energy | Renshuo Solar, Gazer, Jingwei Shida | 3 | 80 | 18 | 7 | •••@sndvc.com | 86-512••• | In the CSV |
| 9 | Huatai Zijin Investment | Nanjing | Hardware, Energy | TETRA Electronic, Zinsight, Puguang Bio | 3 | 66 | 22 | 8 | •••@gmail.com | 025-83••• | In the CSV |
| 10 | SR Capital | Suzhou | Commerce, Hardware | Dongsheng, TICA New Materials, Forsense | 61 | 8 | 3 | ||||
| 11 | Wuxi Capital | Wuxi Shi | Hardware, Health care | Muchuang, Kai Medtech, Etern | 5 | 56 | 19 | 3 | •••@wxfig.com | 0510-8••• | In the CSV |
| 12 | Nanjing Innovation Capital Group | Nanjing | Artificial intelligence, Biotech | Juxie Intelligent, Hengmai Micro, Weikaier Pharmaceutical Technology | 4 | 43 | 9 | 1 | •••@njicg.com | 025-86••• | |
| 13 | Zijin High-Tech Venture Capital | Nanjing | Hardware, Artificial intelligence | eCloudTech | 1 | 38 | 15 | 0 | •••@163.com | ||
| 14 | Yongxin Capital | Suzhou | Hardware, Energy | Zongwei Automation | 1 | 31 | 10 | 0 | |||
| 15 | Bondshine Capital | Nanjing | Energy, Artificial intelligence | Suqian Times Energy Storage, Kaiosi Data Technology, Vantron | 31 | 8 | 2 | 025-86••• | |||
| 16 | Zhidao Capital | Suzhou | Artificial intelligence, Health care | AI Prime, Kuhan Technology | 28 | 6 | 0 | ||||
| 17 | Ming Bioventures | Suzhou | Health care, Biotech | Kossel Medical | 1 | 27 | 12 | 2 | 0512-8••• | ||
| 18 | Leadervc.com | Suzhou | Cybersecurity, Hardware | Prosemi, Chuhui Intelligent, SmartSecuri | 26 | 5 | 1 | •••@leadervc.com.cn | 0512-6••• | ||
| 19 | Wuxi Innovation Investment Group | Wuxi Shi | 24 | 8 | 0 | •••@wuxicapital.com.cn | 0510-8••• | ||||
| 20 | Sunz Fund | Changsha | Health care, Biotech | Barty Medical, Maybio Matrix | 2 | 23 | 10 | 0 | •••@sunzfund.com | 0731-8••• | |
| 21 | Wuxi New District Investment Group | Wuxi Shi | Biotech, Fintech | APTBIO, Filan Air, CYNOVO | 22 | 2 | 2 | •••@wxvc.com.cn | 0510-8••• | ||
| 22 | Czhang's Digital Investment | Taiwan | Software | Gritti | 22 | 0 | 1 | ||||
| 23 | Breakthrough Capital | Nanjing | Health care, Fintech | MetWare, Sino-Biocan, Kindo | 17 | 0 | 0 | ||||
| 24 | FineWill Capital | Suzhou | Hardware | Oneness Labs, O-Cubes, Orthogonal | 16 | 6 | 1 | ||||
| 25 | Qianrong Venture Capital | Suzhou | Hardware | Junfeng New Materials, Yidon Technologies, Lingrui Semiconductor | 16 | 6 | 0 | ||||
| 26 | Rongtuo Capital Management | Wujiang | Energy, Biotech | Zhongke Qingneng | 1 | 16 | 4 | 0 | •••@126.com | 010-88••• | |
| 27 | Ecovacs | Suzhou | Hardware, Artificial intelligence | Inspire-Robots | 1 | 15 | 1 | 2 | 844 32••• | In the CSV | |
| 28 | Guoqian Venture Capital | Haimen | 14 | 2 | 0 | •••@guoqianvc.com | 0513-6••• | In the CSV | |||
| 29 | Jucheng Capital | Nanjing | Hardware | SiVision Technology, Guangheng Technology, Nameda Optoelectronics | 14 | 1 | 0 | •••@juchengcapital.com | 025-86••• | ||
| 30 | Winfast Holding | Nanjing | Hardware, Health care | Zhiren Jingxing, Borns Robot | 14 | 0 | 2 | •••@jiangsuruihua.com | 025-83••• | In the CSV |
Table 1. Venture capital firms in Jiangsu, China: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 9 November 2026. Base: 109.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Addor Capital | Nanjing | 7 | 59 | Micronano Core, Layerwave Bio, Kunwei Technology |
| 2 | Oriza Holdings | Suzhou | 7 | 41 | Mogulinker Technology, Muchuang, Listenai |
| 3 | Highlight Capital | Nanjin | 5 | 14 | EdgeRock, Artivila Therapeutics, ENGINEAI |
| 4 | BioVenture | Suzhou | 5 | 21 | AusperBio, Degron Therapeutics, AccuPulse |
| 5 | Wuxi Capital | Wuxi Shi | 5 | 21 | Muchuang, Kai Medtech, Etern |
| 6 | Nanjing Innovation Capital Group | Nanjing | 4 | 6 | Juxie Intelligent, Hengmai Micro, Weikaier Pharmaceutical Technology |
| 7 | Oriza Seed Capital (Oriza Yuandian) | Suzhou | 4 | 17 | Mogulinker Technology, Simnova, Aerofugia |
| 8 | Suzhou International Development Venture Capital | Suzhou | 4 | 15 | Kossel Medical, Zhilun Ultra-Pure, Gazer |
| 9 | SND Ventures Group | Suzhou | 3 | 15 | Renshuo Solar, Gazer, Jingwei Shida |
| 10 | Huatai Zijin Investment | Nanjing | 3 | 5 | TETRA Electronic, Zinsight, Puguang Bio |
| 11 | Sunz Fund | Changsha | 2 | 3 | Barty Medical, Maybio Matrix |
| 12 | Galaxy Capital | Suzhou | 1 | 3 | MaxSense Technology |
| 13 | Yongxin Capital | Suzhou | 1 | 2 | Zongwei Automation |
| 14 | Ming Bioventures | Suzhou | 1 | 3 | Kossel Medical |
| 15 | Qiji Investment | Suzhou | 1 | 2 | Prime Lifescience |
Table 2. Venture capital firms in Jiangsu, China: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 9 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Micronano Core | Micronano Core develops and researches AIoT chip products for intelligent IoT and advanced technology applications. | Artificial intelligence | Hangzhou | Series C | $150.0M | 2026-10-28 | $490.5M | Addor Capital | 11 to 50 | 2021 |
| MaxSense Technology | MaxSense Technology develops autonomous driving systems and industrial operation optimization software. | Software | Shanghai | Series A | $14.9M | 2026-09-29 | $15.3M | Galaxy Capital | 11 to 50 | 2015 |
| Juxie Intelligent | Juxie Intelligent develops and produces harmonic reducers. | Artificial intelligence | Wuxi Shi | Series B | $14.9M | 2026-09-28 | $28.9M | Nanjing Innovation Capital Group | 11 to 50 | 2019 |
| Barty Medical | Barty Medical provides hospital healthcare services to patients. | Health care | Hangzhou | Series D | $29.5M | 2026-09-23 | $46.7M | Sunz Fund | 101 to 250 | 2015 |
| Zongwei Automation | Zongwei Automation researches and develops automation flexibility technology and solutions. | Hardware | Suzhou | Series C | $29.8M | 2026-09-09 | $31.3M | Yongxin Capital | 101 to 250 | 2020 |
| Mogulinker Technology | Mogulinker Technology supplies SaaS software for the post-industrial equipment market. | Artificial intelligence | Shenzhen | Series C | $14.9M | 2026-09-03 | $32.4M | Oriza Seed Capital (Oriza Yuandian), Oriza Holdings | 51 to 100 | 2016 |
| Kossel Medical | Kossel Medical develops and manufactures vascular interventional devices and clinical system solutions. | Health care | Suzhou | Series C | $59.5M | 2026-09-01 | $103.0M | Suzhou International Development Venture Capital, Ming Bioventures | 501 to 1,000 | 2013 |
| AusperBio | AusperBio develops oligonucleotide therapeutics and targeted delivery technologies for treating diseases. | Biotech | Hangzhou | Series C | $120.0M | 2026-08-27 | $357.0M | BioVenture | 51 to 100 | 2019 |
| Simnova | Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. | Biotech | Cambridge | Series B | $59.3M | 2026-08-18 | $87.2M | Oriza Seed Capital (Oriza Yuandian) | 51 to 100 | 2019 |
| Kai Medtech | Kai Medtech markets and sells vascular intervention medical devices. | Health care | Minhang | Series D | $73.9M | 2026-07-28 | $105.3M | Wuxi Capital | 51 to 100 | 2019 |
Table 3. Venture capital firms in Jiangsu, China: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 9 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 155 | 47% |
| Hardware | 117 | 35% |
| Health care | 85 | 26% |
| Artificial intelligence | 63 | 19% |
| Biotech | 43 | 13% |
| Energy | 20 | 6% |
| Commerce | 12 | 4% |
| Cybersecurity | 9 | 3% |
| Fintech | 9 | 3% |
| Education | 6 | 2% |
Table 4. Venture capital firms in Jiangsu, China: portfolio companies by sector. Source: FundingWatcher. Data as of 9 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 90 | 83% |
| Seed investors | 45 | 41% |
| Late stage investors | 26 | 24% |
| Venture investors | 22 | 20% |
| Private equity investors | 10 | 9% |
| Post IPO investors | 4 | 4% |
Table 5. Venture capital firms in Jiangsu, China by stage they invest at. Source: FundingWatcher. Data as of 9 November 2026.
Cities
| Cities | Investors | Share |
|---|---|---|
| Suzhou | 44 | 40% |
| Nanjing | 27 | 25% |
| Wuxi Shi | 8 | 7% |
| Taiwan | 8 | 7% |
| Changsha | 5 | 5% |
| Zhangjiagang | 3 | 3% |
| Yancheng | 2 | 2% |
| Nanjin | 1 | 1% |
| Xinyi | 1 | 1% |
| Lianyungang | 1 | 1% |
| Wujiang | 1 | 1% |
| Haimen | 1 | 1% |
Table 6. Venture capital firms in Jiangsu, China by headquarters city. Source: FundingWatcher. Data as of 9 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 7 | 10% |
| 2010s | 42 | 58% |
| 2000s | 15 | 21% |
| 1990s | 8 | 11% |
| 1900s | 1 | 1% |
Table 7. Venture capital firms in Jiangsu, China by founding decade. Source: FundingWatcher. Data as of 9 November 2026.
Method
- An investor is on this list when its recorded investor types include venture capital firm and its headquarters is in Jiangsu. On 9 November 2026 that is 109 investors.
- 29 rows carry an email address and 45 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 109 rows: 45 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many venture capital firms in Jiangsu, China are on the list?
- 109, in the file dated 9 November 2026. 23 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 29 of the 109 carry an email address in the download and 45 a phone number.
- What does the CSV contain?
- One row per investor, 14 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 109 rows, no account. Every investor and every startup, two files, cost $299. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 109 rows, 29 firm email addresses and 45 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 7 of the 29 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 25 rows.
- How current is the data?
- The file is dated 9 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 25-row sample first. No account, no payment.